Xi'an Lijun Pharmaceutical Co,.Ltd

Xi?an Lijun Pharmaceutical Co.,Ltd is the largest comprehensive foreign-owned pharmaceutical enterprise in Northwest China with 73 years history. The total assets is more than 10 billion yuan. There are more than 2,400 employees. Xi?an Lijun has over 400 types of pharmaceutical preparations, including tablets, capsules, soft capsules, granules, liquid injections, powder injections, lyophilized powder injections, oral liquid etc. The ?lijunsha?(Erythromycin Ethylsuccinate Preparations) and ?paiqi?(Azithromycin Preparations) are identified as well-known brands in China. The ?lijunsha?(Erythromycin Ethylsuccinate Preparations) has won the title of ?China Top Ten Public Favorite Brands?. Xi'an Lijun is obtained the authentication of ISO14001. Erythromycin have been certified by USFDA and got Europe COS authentification. Erythromycin Phosphate has been certified by USFDA. The APIs have successively been exported to US, Europe, Southeast Asia and South America etc. over 10 years. Xi?an Lijun not only has set up the ?Post-doctoral Research Station ? and ?China National Enterprise Technical Center? but also a strict quality management system. There are more than 200 eligible managing staff in QA and QC Department, and the adherence to the policy of "excellent quality&diligent pursuing" in successive years. Xi?an Lijun has been listed in Hong Kong in 2005 and its stock code is 2005.